Kansas City Precision Oncology Conference

Kansas City, MO US
March 8, 2025

This accredited continuing education activity, Kansas City Precision Oncology Conference, is designed to improve the care of cancer patients by educating cancer care providers about precision oncology. This oncology conference features leading experts in the field of precision oncology who will provide a comprehensive overview of the implications of actionable molecular alterations across common malignancies.
This activity is designed to facilitate learning, improve knowledge retention, and inspire participants to implement the newly acquired knowledge into their clinical practice. Through didactic lectures, case-based discussions, and interactive questions and answer sessions, participants will be able to ask relevant questions, clarify concerns, and network with expert faculties. 

Target Audience

  • Hematologists/ Oncologists
  • Oncology Fellows
  • NPs/PAs
  • Pharmacists
  • Nurses
  • Researchers and others

ORGANIZING COMMITTEE: 

Course Director:

Binay Shah, MD, MHA - Binaytara Foundation

Conference Chair:

Anup Kasi, MD, MPH - University of Kansas Medical Center

Learning Objectives

Upon successful completion of this educational activity, participants will be able to:

  • Identify common molecular abnormalities across several prevalent malignancies and review the appropriate timing of testing to detect these abnormalities
  • Interpret results of next-generation sequencing and other predictive biomarkers to assess responses to targeted therapies, while recognizing associated challenges.
  • Describe the role, including advantages and limitations, of various testing methodologies available for selecting targeted therapies.
  • Develop optimal molecular-targeted treatment strategies for the management of patients with cancer.
  • Summarize emerging research, mechanisms of action, and roles of novel molecular-targeted therapies in the clinical investigation of cancer patients.
     

HOTEL INFORMATION

Embassy Suites by Hilton Kansas City International Airport
7640 NW Tiffany Springs Pkwy
Kansas City, MO 64153
United States
 

GLOBAL ONCOLOGY PROJECT

Click this link to learn more about our ongoing project building a 200-bed cancer hospital in Nepal: https://binayfoundation.org/cancer-hospital/

Course summary
Available credit: 
  • 5.00 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.00 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 5.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 5.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 5.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 5.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 5.00 Contact Hours.
Course opens: 
10/08/2024
Course expires: 
07/08/2025
Event starts: 
03/08/2025 - 8:00am PST
Event ends: 
03/08/2025 - 5:00pm PST
Cost:
$150.00

Saturday, March 8, 2025

All times are listed in Central Standard Time (CST)

07:00 AM – 08:00 AM  Registration, Breakfast, & Exhibits


08:00 AM – 08:05 AM  Welcome

08:05 AM – 08:25 AM  Binaytara Foundation's Efforts in Improving Cancer Care Disparities 


08:25 AM – 09:45 AM  Session 1 - Precision Oncology - General Concepts

Session Chair: Wei Zhang, MD, PhD

08:25 AM – 08:45 AM  Ct-DNA in Clinical Practice: Current Standards and Emerging Roles - Weijing Sun, MD, FACP

08:45 AM – 09:05 AM  Updates on Germline Testing for Hereditary Cancer Syndromes - Jordyn Koehn, MS, CGC

09:05 AM – 09:45 AM  Case-Based Discussion: Sarcoma - Nina S Mathew, MD;  Elizabeth Countee, MS, CGC

             Case 1: Sarcoma 

             Case 2: Lynch Syndrome                         


09:45 AM – 10:15 AM  Break & Exhibits


10:15 AM – 10:55 AM  Session 2 - GI Oncology

Session Chair: Anup Kasi, MD, MPH

10:15 AM – 10:35 AM  Genomics in GI Cancers 

10:35 AM – 10:55 AM  Case-Based Discussion: Targeted Therapies and Immunotherapy in GI Cancers - Marc T. Roth, MD; Jaswinder Singh, MD


10:55 AM – 11:35 AM  Session 3 - Breast Cancer

Session Chair: Qamar J. Khan, MD

10:55 AM – 11:15 AM  Genomics in Breast Cancer - Yiduo Hu, MD, PhD

11:15 AM – 11:35 AM  Case-Based Discussion - Whitney L. Hensing, MD


11:35 AM – 12:35 PM  Lunch & Exhibits


12:35 PM – 01:15 PM  Session 4 - GU Oncology

Session Chair: Rahul A. Parikh, MD, PhD

12:35 PM – 12:55 PM  Genomics in GU Cancer - Haoran Li, MD, PhD

12:55 PM – 01:15 PM  Case-Based Discussion - Vinay Gupta, MD; Saqib H Abbasi, MD


01:15 PM – 01:55 PM  Session 5 - Lung Cancer

Session Chair: Chao H. Huang, MD FACP

01:15 PM – 01:35 PM  Genomics in Lung Cancer - Jun Zhang, MD, PhD

01:35 PM – 01:55 PM  Case-Based Discussion: Lung Cancer -  Anusha Chidharla, MD; Vinay Raja, MD


01:55 PM – 02:20 PM  Break & Exhibits


02:20 PM – 03:20 PM  Session 6 - Hematology

Session Chair: Al-Ola Abdallah, MD

02:20 PM – 02:40 PM  Multiple Myeloma - Nausheen Ahmed, MD

02:40 PM – 03:00 PM  Myeloid Disorders - Abdulraheem Yacoub, MD

03:00 PM – 03:20 PM  Case-Based Discussion: Lymphoma - Marc S. Hoffmann, MD; Aung Tun, MD


03:20 PM  Adjourn

Embassy Suites by Hilton Kansas City International Airport
7640 NW Tiffany Springs Pkwy
Kansas City, MO 64153
United States

IDENTIFICATION AND MITIGATION OF POTENTIAL CONFLICT OF INTERESTS:

All conflict of interest has been identified and mitigated for individuals in control of contents.

PLANNING COMMITTEE DISCLOSURE STATEMENT:

None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.

Session Chair(s)

Wei Zhang, MD, PhD

has a financial relationship (Professional Services) with Jazz Pharmaceuticals. Inc;.
Speaker/Topic Presenter(s)

Marc Hoffmann, Associate Professor; Director, Lymphoma Program

has a financial relationship (Independent contractor) with AbbVie;.
has a financial relationship (Independent contractor) with Astra-Zeneca;.
has a financial relationship (Independent contractor) with Genentech;.
has a financial relationship (Independent contractor) with BeiGene;.
has a financial relationship (Independent contractor) with Janssen;.
has a financial relationship (Independent contractor) with ADC Therapeutics;.
has a financial relationship (Independent contractor) with Novartis;.

Haoran Li

has no relevant financial relationships to disclose at this time.

Marc Roth

has a financial relationship (Professional Services) with Total Health;.
has a financial relationship (Professional Services) with Tempus;.
has a financial relationship (Professional Services) with Takeda;.
has a financial relationship (Professional Services) with Astrazeneca;.

Weijing Sun

has a financial relationship (Professional Services) with Ipsen;.
has a financial relationship (Professional Services) with Merk;.
has a financial relationship (Professional Services) with astra zeneca;.

Jun Zhang, MD, PhD

has a financial relationship (Grant Or Contract) with BeiGene;.
has a financial relationship (Grant Or Contract) with AstraZeneca;.

Available Credit

  • 5.00 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.00 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 5.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 5.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 5.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 5.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 5.00 Contact Hours.

If you are interested in exhibiting at this meeting, please visit our exhibit page here - https://education.binayfoundation.org/exhibit-information

 

Price

Cost:
$150.00
Please login or register to take this course.

POLICY ON INDUSTRY EMPLOYEE'S PARTICIPATION IN MARKETING/EDUCATION ACTIVITY AT THE CONFERENCE: 

All marketing and product promotion activities must occur in the designated exhibit hall or product theater space separate from the area where this accredited continuing education takes place. 

The exhibit and product promotion space is reserved only for companies that have purchased marketing and product promotion slots at the conference.  The individual registration fee doesn't include marketing or product theater privileges. Please refer to the sponsorship handbook for the types of marketing activities included in your display/sponsorship fees. 

If your company has NOT purchased a marketing opportunity such as an exhibit table, product theater slot or another type of marketing opportunity, you may not participate in any marketing activity or attempt to educate healthcare providers about your product or service. Industry attendees of companies without marketing opportunities must refrain from interacting with healthcare providers at this meeting in any form, including introducing themselves as an employee of the company, discussing the care of patients, handing out flyers and brochures, inviting participants to the company's other programs, etc.

Violating this policy will result in a fine equivalent to a general display fee for that conference. 

 

NOTICE TO HCPS EMPLOYED BY THE INDUSTRY:

If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:

  • If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
  • If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event. 
  • If your company has NOT purchased a display table at the event AND you attended the meeting paying a full industry registration fee, BUT YOU PARTICIPATED IN MARKETING AND PROMOTIONAL ACTIVITIES, you will be billed a full GENERAL DISPLAY FEE for that event. 

Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again.

CANCELLATION POLICY

You may cancel your enrollment at any time. Cancellation fees apply as below:

  • 50% of the paid registration fee will be refunded if registration is canceled six weeks before the conference.
  • No refunds will be issued if registration is canceled after that date.  

No credits will be offered if you do not complete all required steps of this activity, including registration and participation in the live meeting.

Required Hardware/software

Morbi tristique senectus et netus et malesuada fames ac turpis.